GammaGard Liquid, Immune Globulin Intravenous (Human)
admin | Jun 08, 2010
Market withdrawal due to an increased number of adverse event reports of allergic reactions associated with two lots.
Related Posts:
- Hylenex recombinant (hyaluronidase human injection): Recall
- Cleviprex (clevidipine butyrate): Recall
- WinRho SDF (Rho(D) Immune Globulin Intravenous (Human): Risk of Intravascular Hemolysis
- Trilipix (fenofibric acid): Drug Safety Communication – Label Change
- Baxter HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems: Class I Recall
Filed Under: Dangerous Drugs





